Analysis Compliance Government Healthcare 
Collibra
MAY 5, 2022
Pharmaceutical, biotech and medical devices firms, among others, must comply with a plethora of regulations. This requires every company to perform gap analysis to determine what is required and then update their systems, processes, workflows and data management strategy accordingly to ensure compliance.
IBM Big Data Hub
MAY 9, 2024
The healthcare industry faces arguably the highest stakes when it comes to data governance. The impact of healthcare data usage on people’s lives lies at the heart of why data governance in healthcare is so crucial.In healthcare, managing the accuracy, quality and integrity of data is the focus of data governance.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
erwin
MARCH 25, 2021
erwin recently hosted the second in its six-part webinar series on the practice of data governance and how to proactively deal with its complexities. Led by Frank Pörschmann of iDIGMA GmbH, an IT industry veteran and data governance strategist, the second webinar focused on “ The Value of Data Governance & How to Quantify It.”.
erwin
NOVEMBER 6, 2019
erwin released its State of Data Governance Report in February 2018, just a few months before the General Data Protection Regulation (GDPR) took effect. Download Free GDPR Guide | Step By Step Guide to Data Governance for GDPR?. Data governance maturity includes the ability to rely on automated and repeatable processes.
erwin
AUGUST 13, 2020
Today, enterprises are trying to grow and innovate – while cutting costs and managing compliance – in the midst of a global pandemic. Compliance and Legislation : How do we manage uncertainty around legislative change (e.g., Taking months to perform impact analysis and solution design is no longer viable, and data has to be agile.
IBM Big Data Hub
AUGUST 7, 2023
Despite advancements in the pharmaceutical industry and biomedical research, delivering drugs to market is still a complex process with tremendous opportunity for improvement. Additionally, biopharma companies may find themselves building out AI capabilities in-house sporadically and without overarching governance.
Reltio
SEPTEMBER 13, 2022
This allows those teams to focus more on higher value-added research and data analysis. Customers interviewed in the study were from the pharmaceuticals, technology, insurance and retail industries. They managed their data sources with a hybrid of primarily on-premises, third-party tools and in-house, customized solutions.
Expert insights. Personalized for you.
91 
Let's personalize your content